Skip to main content
Figure 1 | BMC Medicine

Figure 1

From: Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy

Figure 1

Distribution of participation in the screening. Flowchart of the two screening phases, showing the distribution of participants by Finnish Diabetes Risk Score (FINDRISC) results and the three sets of diagnostic criteria: 2-hour plasma glucose (2hPG), fasting plasma glucose (FPG), and hemoglobin (Hb)A1c.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us